Insider trades

Daniel Janney, Director of Krystal Biotech KRYS, has filed 0 purchases and 34 sales on the open market. Over the past 12 months that comes to a net sale of $19.4M. The latest trade was on 02/27.

Daniel Janney

Director
First filing
23/05/30
Trades
40 trades
Buys / sales
0 / 34
12-month net buying
−$19.4M
Last trade
02/27

Trading activity

Transactions

Trade type
KRYS
Open-market sale10b5-1 plan02/2703/0311,803 sh2 trades$275.59avg.$3,252,844.91−13.9%
KRYS
Open-market sale10b5-1 plan02/24–02/2602/2660,161 sh20 trades$268.44avg.$16,149,459.41No record
KRYS
Open-market sale23/06/08–23/06/0923/06/0950,000 sh9 trades$128.36avg.$6,418,119.69−31.8%
Open-market sale10b5-1 plan23/05/1923/05/2350,000 sh$95.02$4,751,000−24.1%
Open-market sale10b5-1 plan23/05/0923/05/1117,100 sh$90.74$1,551,654−7.6%
Open-market sale10b5-1 plan23/04/1923/04/217,900 sh$90.32$713,528−3.4%